Click
Chat
 
Du kan vedhæfte PDF, JPG, PNG, DOC(X), XLS(X) og TXT-filer. Klik på ikonet, vælg fil og vent til upload er færdig før du indsender eller uploader endnu en fil.
60
Vedhæft Send
Historik

Vælg chat via ovenstående menu
Luk reklame

Q&A med Genmab A/S, 26 Februar Kl. 14:30 Læs mere her
      

Index Ventures og Genmab


22683 akademikeren 27/11 2009 00:57
Oversigt

mark de boer index
Index Ventures, a Europe-based venture capital firm, today announced the closing of Index Ventures IV, bringing the firm's total capital under management to more than ?1 billion. A small group of new investors joined existing investors the new fund which was capped at ?350M. Index Ventures IV will pursue the firm's strategy of partnering with highly talented entrepreneurs to build global companies in the information technology, life science and green tech sectors.

The firm also announced today the addition of former Skype global marketing vice president and Video Island founder Saul Klein as a venture partner. The firm also announced additions to its life science team with the appointment of PanGenetics founder Mark De Boer to venture partner and the promotion of experienced pharmaceutical executive, Michèle Ollier, to partner.

"We are grateful for the support of our investors and the dedication and vision of the entrepreneurs who have worked with us to put European venture capital on the map," said David Rimer, a general partner with Index. "We are excited as ever to be tapping into the growing talent pool we see in Europe."

Since its inception in 1996, Index Ventures has backed visionary entrepreneurs who have taken on incumbents and built seminal companies in a number of growth sectors including: open source software companies such as MySQL, Trolltech, Zend and Pentaho; broadband and VOIP companies such as Virata, Skype, FON and Rebtel; Internet service companies such as Betfair, Oanda, Last.fm, SpotRunner, Lovefilm, Stardoll and Netvibes; and life science companies such as Genmab, ParAllele Biosciences, BioXell, 7TM Pharma, Addex Pharmaceutical and PanGenetics.

"Everything we do is about helping entrepreneurs move quickly to become global market leaders," said Index Ventures general partner, Bernard Dallé. "Success for European companies has depended on their ability to extend their geographical reach quickly and cost-effectively. We invest in entrepreneurial teams going after global opportunities, whether they are in Tallinn, Toronto, Los Angeles, London or Madrid."

About Index Ventures

Index Ventures has been active in technology venture investing since 1996. The firm is dedicated to helping great entrepreneurial teams in the life science and information technology sectors build their companies into market-defining global leaders. The firm has offices in Geneva, London and Jersey, UK. Landmark investments include Genmab, one of the largest antibody companies in the world, Betfair, the world's largest betting exchange and Skype, recently sold to eBay. For more information visit http://www.indexventures.com.



27/11 2009 14:02 akademikeren 022710






TRÅDOVERSIGT